Sample preparation including cold acetone precipitation followed by denaturing PAGE using NuPAGE 10% Bis-Tris and 3–8% Tris-Acetate precast gels (Life Technologies) as well as detection of in-gel fluorescence and autoradiography were performed as described previously and in accordance to the manufacturer’s instructions6. Due to increased protein concentrations resulting from utilization of the CrPV-IRES the amount of sample applied to the denaturing page was reduced to correspond to 2.5 μl of the initial fractions from the cell-free reactions.
Immunoblotting was performed using the “IBlot Gel Transfer Device” (Life Technologies) according to the manufacturer’s instructions. Following denaturing PAGE (3–8% Tris-Acetate) proteins were transferred to a PVDF membrane (Life Technologies). The membrane was blocked in “Roti-Block” (Roth) for 4 hours and subsequently incubated with “EGF Receptor (D38B1) XP® Rabbit mAb 4267” or “Phospho-EGF Receptor (Tyr1068) (D7A5) XP® Rabbit mAb 3777” primary antibodies diluted 1:1000 over night at 4 °C. “Anti-rabbit IgG, HRP-linked Antibody 7074” diluted 1:2000 was used as a secondary antibody and detection was carried out using the “Amersham ECL Prime Western Blotting Detection Reagent” (GE Healthcare) and the “Typhoon Trio + Variable Mode Imager” (GE Healthcare). All antibodies were purchased from “Cell Signaling Technology Inc.”. After detection, blotting membranes were dried and subjected to autoradiography.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.